Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients
暂无分享,去创建一个
R. McWilliams | S. Markovic | Haidong Dong | M. Block | L. Kottschade | R. Dronca | J. Paludo | J. Vera Aguilera | Henan Zhang | Yiyi Yan | A. Kumar | Jarrett J. Failing | Ying Li